Table 3 Similarity (%) to individual donor lots. Similarity was assessed only on patients who were treated using the individual donor lot. Fecal material from donor 42 was not available for sequencing
Clinical outcome | Time point | 06 | 20 | 41A | 41B | 41C | 44 | 62 |
|---|---|---|---|---|---|---|---|---|
| Â | n* | 22 | 3 | 1 | 30 | 5 | 19 | 10 |
|  | pre-FMT | 13.3 ± 4.6 | 18.7 ± 16.0 | 67.0 | 6.1 ± 1.8 | 8.2 ± 9.2 | 12.0 ± 4.5 | 25.0 ± 6.9 |
Response | Days | 34.5 ± 5.8 | 45.9 ± 14.4 | 50.3 | 16.7 ± 3.9 | 24.2 ± 1.6 | 35.0 ± 5.7 | 51.7 ± 9.2 |
Weeks | 49.8 ± 4.4 | 47.0 ± 17.1 | 56.4 | 34.8 ± 2.7 | 23.9 ± 17.0 | 45.0 ± 5.3 | 52.3 ± 5.1 | |
Months | 55.0 ± 5.0 | NC | NC | 39.2 ± 3.9 | 57.8 | 57.1 ± 5.1 | 47.5 ± 6.8 | |
Long-term | 53.8 ± 6.2 | NC | 38.2 | 34.2 ± 3.2 | 73.4 | 42.2 ± 5.1 | NC | |
Recurrence | Days | 29.0 ± 12.7 | NC | NC | 23.2 ± 9.4 | 36.5 ± 51.6 | 22.6 ± 11.1 | 37.8 ± 12.4 |
Weeks | 42.0 ± 7.9 | NC | NC | 26.9 ± 5.8 | 34.8 ± 26.6 | 35.3 ± 6.9 | 53.9 ± 10.9 |